Furthermore, there was no statistically significant correlation between the positive rate of CNN2 antigen and clinical indicators of HCC patients, such as age, AFP value, tumor pathological grade, and γ-glutamyltranspeptidase (GGT) (Supplementary Table S1). Here, CNN2 is linked to hepatocellular carcinoma.